LivaNova Return on Tangible Equity 2010-2025 | LIVN
Current and historical return on tangible equity values for LivaNova (LIVN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| LivaNova Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.22B | $0.04B | -101.25% |
| 2024-12-31 | $0.06B | $0.33B | 24.30% |
| 2024-09-30 | $0.02B | $0.28B | 9.81% |
| 2024-06-30 | $-0.02B | $0.23B | -8.84% |
| 2024-03-31 | $-0.03B | $0.20B | -19.84% |
| 2023-12-31 | $0.02B | $0.23B | 12.64% |
| 2023-09-30 | $0.00B | $0.11B | 3.21% |
| 2023-06-30 | $-0.10B | $0.10B | -128.05% |
| 2023-03-31 | $-0.08B | $0.09B | -169.07% |
| 2022-12-31 | $-0.09B | $0.07B | -312.73% |
| 2022-09-30 | $-0.09B | $0.04B | -1062.86% |
| 2022-06-30 | $-0.03B | $-0.01B | 1657.14% |
| 2022-03-31 | $-0.10B | $0.01B | 135.12% |
| 2021-12-31 | $-0.14B | $-0.01B | 94.41% |
| 2021-09-30 | $-0.41B | $0.00B | 202.44% |
| 2021-06-30 | $-0.39B | $-0.30B | 159.50% |
| 2021-03-31 | $-0.42B | $-0.27B | 202.91% |
| 2020-12-31 | $-0.35B | $-0.25B | 218.47% |
| 2020-09-30 | $-0.21B | $-0.15B | 159.85% |
| 2020-06-30 | $-0.16B | $-0.15B | 124.71% |
| 2020-03-31 | $-0.11B | $-0.08B | 73.43% |
| 2019-12-31 | $-0.16B | $-0.14B | 88.64% |
| 2019-09-30 | $-0.22B | $-0.15B | 111.92% |
| 2019-06-30 | $-0.26B | $-0.20B | 170.13% |
| 2019-03-31 | $-0.22B | $-0.22B | 219.10% |
| 2018-12-31 | $-0.19B | $-0.22B | -987.01% |
| 2018-09-30 | $-0.09B | $0.03B | -45.67% |
| 2018-06-30 | $-0.06B | $0.02B | -18.95% |
| 2018-03-31 | $-0.02B | $0.25B | -6.27% |
| 2017-12-31 | $-0.03B | $0.50B | -6.08% |
| 2017-09-30 | $0.06B | $0.42B | 12.53% |
| 2017-06-30 | $0.03B | $0.37B | 5.76% |
| 2017-03-31 | $-0.01B | $0.43B | -2.56% |
| 2016-12-31 | $-0.06B | $0.57B | -13.79% |
| 2016-06-30 | $-0.06B | $0.43B | -14.99% |
| 2016-03-31 | $-0.09B | $0.39B | -33.93% |
| 2015-10-31 | $-0.03B | $0.27B | -18.87% |
| 2015-07-31 | $0.04B | $0.28B | 25.50% |
| 2015-06-30 | $0.04B | 30.42% | |
| 2015-03-31 | $0.06B | 30.57% | |
| 2014-10-31 | $0.05B | $0.26B | 18.24% |
| 2014-07-31 | $0.04B | $0.25B | 17.65% |
| 2013-10-31 | $0.04B | $0.22B | 16.23% |
| 2013-07-31 | $0.04B | $0.23B | 16.72% |
| 2012-10-31 | $0.03B | $0.20B | 17.58% |
| 2012-07-31 | $0.03B | $0.18B | 15.65% |
| 2011-10-31 | $0.02B | $0.16B | 13.90% |
| 2011-07-31 | $0.04B | $0.16B | 23.74% |
| 2010-10-31 | $0.04B | $0.16B | 34.24% |
| 2010-07-31 | $0.07B | $0.12B | 64.23% |
| 2009-10-31 | $0.07B | $0.09B | 167.90% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.289B | $1.253B |
| LivaNova PLC is a medical technology company which focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company's operating units consists of Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. LivaNova PLC, formerly known as Cyberonics, Inc., is based in London, United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $185.883B | 81.42 |
| Thermo Fisher Scientific (TMO) | United States | $156.566B | 18.94 |
| Edwards Lifesciences (EW) | United States | $44.869B | 29.42 |
| Alcon (ALC) | Switzerland | $43.085B | 29.12 |
| IDEXX Laboratories (IDXX) | United States | $41.386B | 47.56 |
| DexCom (DXCM) | United States | $32.894B | 50.84 |
| IQVIA Holdings (IQV) | United States | $27.789B | 15.56 |
| Mettler-Toledo (MTD) | United States | $24.833B | 29.53 |
| STERIS (STE) | Ireland | $22.191B | 24.44 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.420B | 0.00 |
| Waters (WAT) | United States | $17.111B | 24.14 |
| Hologic (HOLX) | United States | $14.260B | 15.49 |
| Sysmex ADR (SSMXY) | Japan | $10.443B | 29.62 |
| Penumbra (PEN) | United States | $8.922B | 70.02 |
| Masimo (MASI) | United States | $8.375B | 30.89 |
| Globus Medical (GMED) | United States | $7.627B | 18.17 |
| Glaukos (GKOS) | United States | $5.583B | 0.00 |
| Teleflex (TFX) | United States | $4.908B | 8.10 |
| Integer Holdings (ITGR) | United States | $3.925B | 20.56 |
| TransMedics (TMDX) | United States | $3.717B | 80.79 |
| PROCEPT BioRobotics (PRCT) | United States | $3.228B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.899B | 17.07 |
| Nihon Kohden (NHNKY) | Japan | $1.863B | 21.37 |
| Veracyte (VCYT) | United States | $1.841B | 25.84 |
| Alphatec Holdings (ATEC) | United States | $1.533B | 0.00 |
| Artivion (AORT) | United States | $1.302B | 121.96 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.016B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.984B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.865B | 4.60 |
| IRadimed (IRMD) | United States | $0.721B | 36.57 |
| SiBone (SIBN) | United States | $0.708B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.589B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.564B | 12.24 |
| OrthoPediatrics (KIDS) | United States | $0.535B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.519B | 8.07 |
| AxoGen (AXGN) | United States | $0.514B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.416B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.411B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.385B | 8.96 |
| Treace Medical Concepts (TMCI) | United States | $0.355B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.353B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.309B | 0.00 |
| RxSight (RXST) | United States | $0.299B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.258B | 0.00 |
| Neuronetics (STIM) | United States | $0.242B | 0.00 |
| 908 Devices (MASS) | United States | $0.240B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.221B | 13.41 |
| CVRx (CVRX) | United States | $0.209B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
| Inogen (INGN) | United States | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.149B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.110B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.109B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 43.40 |
| Spectral AI (MDAI) | United States | $0.064B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.11 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.17 |